Primary Aldosteronism

PA patients have a higher cardiovascular morbidity and mortality than patients with essential hypertension. Guidelines recommend determination of the plasma aldosterone/renin ratio (ARR) to detect PA in patient groups with relatively high PA prevalence, including patients suffering from severe or drug resistant hypertension.